A nurse working for a drug company is involved in phase III drug evaluation studies. Which of the following might the nurse be responsible for during this stage of drug development?
A) Working with animals who are given experimental drugs
B) Monitoring drug effects in patients who are selected to participate in a study, who have the disease that the drug is meant to treat
C) Administering investigational drugs to patients
D) Informing healthy, young volunteer participants of possible risks that could occur from taking an experimental drug
Question 2
Following a bilateral mastectomy, a 55-year-old female patient is being discharged home with a prescription for an opioid analgesic as well as daily subcutaneous injections of enoxaparin (Levonix), a low-molecular weight heparin for prophylaxis of
thrombosis. What teaching point should the nurse prioritize during the patient's discharge planning?
A) The correct technique for drawing up and administering subcutaneous injections
B) The health threats that are posed by deep vein thrombosis and pulmonary embolism
C) The herbal alternatives to enoxaparin
D) The pharmacokinetics of enoxaparin and the relationship with the need for subcutaneous injection of the drug
Cells involved in specific immunity in vertebrates.
Drug Administration Guidelines with Enteral Feedings
The processes involved in urine formation.
A new drug development time line with the four phases of drug approval.
Drug A is more potent than Drugs B and C. Drugs A and C have equal efficacy because both drugs have ...
Clinically Significant Drug-Drug Interactions in Dentistry